P53 protein expression in grade II astrocytomas: Immunohistochemical study of 100 cases with long-term follow-up

Pathology Research and Practice

Volumn 194, Issue 12, 1998, Pages 831-836

  Vital, A ^a   Loiseau, H ^a   Kantor, G ^a   Daucourt, V ^a   Chene, G ^a   Cohadon, F ^a   Rougier, A ^a   Rivel, J ^a   Vital, C ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Follow up; Grade II astrocytoma; p53 protein

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; STAINING;

EID: 0032408841     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(98)80085-X     Document Type: Article

References (32)

1. LM Alderson RL Castleberg GR Harsh IV DN Louis JW Henson Human gliomas with wild-type p53 express bcl-2 Cancer Res 55 1995 999 1001
2. S Al-Sarraj LR Bridges p53 immunoreactivity in astrocytomas and its relationship to survival Br J Neurosurg 9 1995 143 149
3. M Barbareschi P Iuzzolino A Pennella A Allegranza G Arrigoni P Dalla Palma C Doglioni p53 protein expression in central nervous system neoplasms J Clin Pathol 45 1992 583 586
4. JM Bruner H Saya RP Moser Immunocytochemical detection of p53 in human gliomas Mod Pathol 4 1991 671 674
5. BS Chozick JC Pezzullo MH Epstein PW Finch Prognostic implications of p53 overexpression in supratentorial astrocytic tumors Neurosurgery 35 1994 831 838
6. BS Chozick ME Weicker JC Pezzullo CL Jackson SD Finkelstein MW Ambler MH Epstein PW Finch Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis Cancer 73 1994 406 415
7. RA Danks G Chopra MF Gonzales JM Orian AH Kaye Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma Neurosurgery 37 1995 246 254
8. DW Ellison KC Gatter PV Steart DP Lane RO Weller Expression of the p53 protein in the spectrum of astrocytic tumours J Pathol 168 1992 383 386
9. DW Ellison PV Steart AC Bateman RM Pickering JD Palmer RO Weller Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies J Neurol Neurosurg Psychiatry 59 1995 413 419
10. D Fults D Brockmeyer MW Tullous CA Pedone RM Cawthon p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression Cancer Res 52 1992 674 679
11. H Haapasalo J Isola P Sallinen H Kalimo H Helin I Rantala Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation Am J Pathol 142 1993 1347 1351
12. P Iuzzolini C Ghimenton A Nicolato F Giorgiutti P Fina C Doglioni M Barbareschi p53 protein in lowgrade astrocytomas: a study with long-term follow-up Br J Cancer 69 1994 586 591
13. E Jaros RH Perry L Adam PJ Kelly PJ Crawford RM Kalbag AD Mendelow RP Sengupta ADJ Pearson Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumors Br J Cancer 66 1992 373 385
14. E Karamitopoulou E Perentes I Diamantis p53 protein expression in central nervous system tumors: an immunohistochemical study with CMl polyvalent and D0-7 monoclonal antibodies Acta Neuropathol 85 1993 611 616
15. nd ed. 1993 Springer-Verlag Berlin
16. H Koga S Zhang T Kumanishi K Washiyama T Ichikawa R Tanaka J Mukawa Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry Acta Neuropathol 87 1994 225 232
17. R Kordek W Biernat J Alwasiak R Maculewicz R Yanagihara PP Liberski p53 protein and epidermal growth factor receptor expression in human astrocytomas J Neurooncol 26 1995 11 16
18. AP Kyritsis R Xu ML Bondy VA Levin JM Bruner Correlation of p53 immunoreactivity and sequencing in patients with glioma Mol Carcinog 15 1996 1 4
19. FF Lang DC Miller S Pisharody M Koslow EW Newcomb High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas Oncogene 9 1994 949 954
20. H Loiseau JF Dartigues F Cohadon Low gradeastrocytomas: prognosis factors and elements of management Surg Neurol 44 1995 224 227
21. DN Louis A von Deimling RY Chung MP Rubio JM Whaley RH Eibl H Ohgaki OD Wiestler AD Thor BR Seizinger Comparative study of p53 gene and protein alterations in human astrocytic tumors J Neuropathol Exp Neurol 52 1993 31 38
22. DN Louis The p53 gene and protein in human brain tumors J Neuropathol Exp Neurol 53 1994 11 21
23. EW Newcomb WJ Madonia S Pisharody FF Lang M Koslow DC Miller A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme Brain Pathol 3 1993 229 235
24. HK Ng SY Lo DP Huang WS Poon Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors Pathology 26 1994 1 5
25. Y Ono T Tamiya T Ichikawa K Matsumoto T Furuta T Ohmoto K Akiyama S Seki K Ueki DN Louis Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression Acta Neuropathol 94 1997 21 27
26. MP Rubio A von Deimling DW Yandell OD Wiestler JF Gusella DN Louis Accumulation of wild type p53 protein in human astrocytomas Cancer Res 53 1993 3465 3467
27. D Sidransky T Mikkelsen K Schwechheimer ML Rosenplum W Cavanee B Vogelstein Clonal expansion of p53 mutant cells is associated with brain tumor progression Nature 355 1992 846 847
28. DJ van Meyel DA Ramsay AG Casson M Keeney AF Chambers JG Caimcross p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression J Natl Cancer Inst 86 1994 1011 1017
29. A von Deimling RH Eibl H Ohgaki DN Louis K von Ammon I Petersen P Kleihues RY Chung OD Wiestler BR Seizinger p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma Cancer Res 52 1992 2987 2990
30. A von Deimling K von Ammon D Schoenfeld OD Wiestler BR Seizinger DN Louis Subsets of glioblastoma multiforme defined by molecular genetic analysis Brain Pathol 3 1993 19 26
31. K Watanabe O Tachibana K Sato Y Yonekawa P Kleihues H Ohgaki Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas Brain Pathol 6 1996 217 224
32. H Yaziji R Massarani-Wafai M Gujrati JG Kuhns AW Martin JC Parker Role ofp53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions Am J Surg Pathol 20 1996 1086 1090